Co-administration of morphine and oxycodone vaccines reduces the distribution of 6-monoacetylmorphine and oxycodone to brain in rats

Vaccine

Volumn 30, Issue 31, 2012, Pages 4617-4624

  Pravetoni, M ^a,b   Raleigh, M D ^b   Le Naour, M ^c   Tucker, A M ^a   Harmon, T M ^a   Jones, J M ^c   Birnbaum, A K ^c   Portoghese, P S ^b,c   Pentel, P R ^a,b  

^a MINNEAPOLIS MEDICAL RESEARCH FOUNDATION   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Addiction; Antibodies; Heroin; Oxycodone; Prescription opioids; Vaccine

Indexed keywords

ANTIGEN; DIAMORPHINE; HAPTEN; KEYHOLE LIMPET HEMOCYANIN; MORPHINE; MORPHINE 6 ACETATE; OXYCODONE; VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY TITER; ARTICLE; BRAIN; CONTROLLED STUDY; DRUG EFFICACY; IMMUNIZATION; IMMUNOGENICITY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SINGLE DRUG DOSE;

ANIMALS; ANTIBODIES; ANTIBODY SPECIFICITY; BRAIN; CROSS REACTIONS; HAPTENS; HEROIN; MALE; MICE; MICE, INBRED BALB C; MORPHINE; MORPHINE DERIVATIVES; OXYCODONE; RATS; VACCINES; VACCINES, COMBINED;

EID: 84861982138     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.04.101     Document Type: Article

References (27)

1. National Survey on Drug Use and Health: National Findings. U.S. Department Of Health And Human Services Substance Abuse and Mental Health Services AdministrationOffice of Applied Studies 2010; . http://www.oas.samhsa.gov/nsduh/2k8nsduh/2k8Results.cfm.
2. Maxwell J.C. The prescription drug epidemic in the United States: a perfect storm. Drug and Alcohol Review 2011, 30(3):264-270.
3. Compton W.M., Volkow N.D. Abuse of prescription drugs and the risk of addiction. Drug and Alcohol Dependence 2006, 83(Suppl. 1):S4-S7.
4. Compton W.M., Volkow N.D. Major increases in opioid analgesic abuse in the United States: concerns and strategies. Drug and Alcohol Dependence 2006, 81(2):103-107.
5. 2008 Department of Defense Survey of Health Related Behaviors Among Active Duty Military Personnel. Department of Defence 2009; . http://www.tricare.mil/2008HealthBehaviors.pdf.
6. Oxymorphone Abuse: A growing Threat Nationwide. Department of Justice 2011; EWS Report 000011; . http://www.justice.gov/ndic/pubs44/44817/sw0011p.pdf.
7. Epidemic: Responding to America's Prescription Drug Abuse Crisis. Executive office of the president of the United States 2011; . http://www.whitehouse.gov/sites/default/files/ondcp/policy-and-research/rx_abuse_plan.pdf.
8. Butler S.F., Black R.A., Cassidy T.A., Dailey T.M., Budman S.H. Abuse risks and routes of administration of different prescription opioid compounds and formulations. Harm Reduction Journal 2011, 8:29.
9. Dodrill C.L., Helmer D.A., Kosten T.R. Prescription pain medication dependence. American Journal of Psychiatry 2011, 168(5):466-471.
10. Wu L.T., Woody G.E., Yang C., Blazer D.G. How do prescription opioid users differ from users of heroin or other drugs in psychopathology: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Journal of Addiction Medicine 2011, 5(1):28-35.
11. Chi K.R. Vaccines move forward against a range of addictions. Nature Medicine 2011, 17(2):146.
12. Hatsukami D.K., Jorenby D.E., Gonzales D., Rigotti N.A., Glover E.D., Oncken C.A., et al. Immunogenicity and smoking-cessation outcomes for a novel nicotine immunotherapeutic. Clinical Pharmacology and Therapeutics 2011, 89(3):392-399.
13. Martell B.A., Orson F.M., Poling J., Mitchell E., Rossen R.D., Gardner T., et al. Cocaine vaccine for the treatment of cocaine dependence in methadone-maintained patients: a randomized, double-blind, placebo-controlled efficacy trial. Archives of General Psychiatry 2009, 66(10):1116-1123.
14. Anton B., Leff P. A novel bivalent morphine/heroin vaccine that prevents relapse to heroin addiction in rodents. Vaccine 2006, 24(16):3232-3240.
15. Anton B., Salazar A., Flores A., Matus M., Marin R., Hernandez J.A., et al. Vaccines against morphine/heroin and its use as effective medication for preventing relapse to opiate addictive behaviors. Human vaccines 2009, 5(4):214-229.
16. Berkowitz B., Spector S. Evidence for active immunity to morphine in mice. Science 1972, 178(67):1290-1292.
17. Berkowitz B.A., Ceretta K.V., Spector S. Influence of active and passive immunity on the disposition of dihydromorphine-H3. Life Sciences 1974, 15(5):1017-1028.
18. Bonese K.F., Wainer B.H., Fitch F.W., Rothberg R.M., Schuster C.R. Changes in heroin self-administration by a rhesus monkey after morphine immunisation. Nature 1974, 252(5485):708-710.
19. Stowe G.N., Vendruscolo L.F., Edwards S., Schlosburg J.E., Misra K.K., Schulteis G., et al. A vaccine strategy that induces protective immunity against heroin. Journal of Medicinal Chemistry 2011, 54(14):5195-5204.
20. Pravetoni M., Le Naour M., Harmon T., Tucker A., Portoghese P.S., Pentel P.R. An oxycodone conjugate vaccine elicits oxycodone-specific antibodies that reduce oxycodone distribution to brain and hot-plate analgesia. Journal of Pharmacology and Experimental Therapeutics 2012.
21. Andersen J.M., Ripel A., Boix F., Normann P.T., Morland J. Increased locomotor activity induced by heroin in mice: pharmacokinetic demonstration of heroin acting as a prodrug for the mediator 6-monoacetylmorphine in vivo. Journal of Pharmacology and Experimental Therapeutics 2009, 331(1):153-161.
22. Bazin-Redureau M.I., Renard C.B., Scherrmann J.M. Pharmacokinetics of heterologous and homologous immunoglobulin G: F(ab')2 and Fab after intravenous administration in the rat. Journal of Pharmacy and Pharmacology 1997, 49(3):277-281.
23. Pravetoni M., Keyler D.E., Pidaparthi R.R., Carroll F.I., Runyon S.P., Murtaugh M.P., et al. Structurally distinct nicotine immunogens elicit antibodies with non-overlapping specificities. Biochemical Pharmacology 2011.
24. Tars K., Kotelovica S., Lipowsky G., Bauer M., Beerli R.R., Bachmann M.F., et al. Different binding modes of free and carrier-protein-coupled nicotine in a human monoclonal antibody. Journal of Molecular Biology 2012, 415(1):118-127.
25. Haney M., Gunderson E.W., Jiang H., Collins E.D., Foltin R.W. Cocaine-specific antibodies blunt the subjective effects of smoked cocaine in humans. Biological Psychiatry 2010, 67(1):59-65.
26. Kantak K.M., Collins S.L., Bond J., Fox B.S. Time course of changes in cocaine self-administration behavior in rats during immunization with the cocaine vaccine IPC-1010. Psychopharmacology 2001, 153(3):334-340.
27. Pravetoni M., Keyler D.E., Raleigh M.D., Harris A.C., Lesage M.G., Mattson C.K., et al. Vaccination against nicotine alters the distribution of nicotine delivered via cigarette smoke inhalation to rats. Biochemical Pharmacology 2011, 81(9):1164-1170.